Pharmaceutics
Best Poster Award: 500 CHF + Publication possibility (Impact Factor: 4.77)
Precision Nanomedicine
Awarded Posters are invited by Precision Nanomedicine for a publication in their journal.
Precision Nanomedicine (prnano.com) is an international, open access, peer-reviewed, non-profit journal owned by the scientific community, that promotes all progressive and rational aspects of nanomedicine including theory, basic research, translation, practice, and commercialization. PRNANO publishes original and replication studies, (i.e., research manuscripts that reproduce, evaluate, and confirm research results) as well as discussions of negative results (i.e. results that do not confirm hypotheses) if they take the field forward. It is the official journal of the European Foundation for Clinical Nanomedicine and listed (among others) in the Directory of Open Access Journals. Submit your manuscript at: https://precisionnanomedicine.com/for-authors
FROST8 Conference
Conference are going exceedingly well and we are confident we will deliver a dynamic, enriching and memorable experience. FROST8 Conference will comprise 3 days of scientific/technical content, including the Keynote presentations, round tables as well as 1-on-1 meetings, providing multiple opportunities to connect with other participants. FROST8 2021 will end with the traditional workshop style Flow Chemistry Academy where exhibitors can present their equipment in operation.
FROST Conference 2021 will be accessible through a virtual platform too, all lectures will be live streamed, and we added also ePosters to enhance the traditional poster boards. We believe this initiative will promote greater interaction and will have great impact.
We are introducing reduced Registration fees to make this year’s FROST Conference widely accessible.
The main body of this year’s FROST8 will be the in-person conference. We urge young scientists to submit their results for Posters and plan to attend the event in-person. It will be truly unforgettable; nothing can really replace the in-person experience.